-- Board Also Elects George F.J. Gosbee To Serve As Chair --
DAVIS, Calif.--(BUSINESS WIRE)--Jun. 13, 2017--
Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology
company that creates value for farmers while benefitting the environment
and enhancing human health, announced today that Eric J. Rey and Gregory
D. Waller have joined its board of directors. The two were elected at
the company’s annual stockholders meeting to replace directors Vic
Knauf, Ph.D and Rajiv Shah, M.D.
Additionally, the board of directors formally elected George F.J. Gosbee
as its chair. Gosbee has served as interim chair of the board since
“We are fortunate to have Eric and Greg join the board, two directors
with the experience, and industry insight needed to help Arcadia grow
the business,” said George Gosbee, chair of the board of directors. “I
would also like to thank Vic Knauf and Raj Shah for their service and
contributions to the board.”
Rey is one of the founders of Arcadia Biosciences and served as
president and CEO, as well as a director, until 2016. Prior to founding
Arcadia, Rey was a partner with Rockridge Group, a management consulting
firm for early-stage companies developing genomic, biopharmaceutical,
nutraceutical, crop protection, animal nutrition and health, alternative
crop and industrial products. He previously served as vice president of
operations with Calgene, Inc., including two years with Monsanto Company
following its acquisition of Calgene. Rey holds a B.S. in plant science
from the University of California, Davis. He currently serves as a
director for Phytelligence, Inc. and Texas Crop Science, LLC.
Waller is the former chief financial officer (CFO) of Ulthera
Corporation, a privately-held company providing ultrasound technology
for aesthetic and medical applications, which was acquired by Merz North
America in 2014. Previously, Waller was CFO of Universal Building
Products and Sybron Dental Specialties, Inc., and vice president and
treasurer of Kerr, Ormco Corporation, and Metrex. Waller has an MBA with
a concentration in accounting from California State University,
Fullerton. He has extensive experience serving on the boards of public
companies and currently serves as a director for Sunshine Heart and
About Arcadia Biosciences, Inc.
Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA) develops
agricultural products that create added value for farmers while
benefitting the environment and enhancing human health. Arcadia’s
agronomic performance traits, including Nitrogen Use Efficiency, Water
Use Efficiency, Salinity Tolerance, Heat Tolerance and Herbicide
Tolerance, are all aimed at making agricultural production more
economically efficient and environmentally sound. Arcadia’s nutrition
traits and products are aimed at creating healthier ingredients and
whole foods with lower production costs. For more information, visit www.arcadiabio.com.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are subject to risks and uncertainties that
could cause actual results to differ materially, and reported results
should not be considered as an indication of future performance. These
risks and uncertainties include, but are not limited to: the company’s
expectations of Eric Rey’s and Greg Waller’s potential contributions as
members of the company’s board of directors and the other risks set
forth in the company’s filings with the Securities and Exchange
Commission from time to time, including the risks set forth in the
company’s annual report on Form 10-K for the year ended December 31,
2016 and other filings. These forward-looking statements speak only as
of the date hereof, and Arcadia Biosciences, Inc. disclaims any
obligation to update these forward-looking statements.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170613005294/en/
Source: Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc.